Tag: Technology transfer

Rights for Four Diagnostic Imaging Agents to be Transferred from Daiichi Sankyo to GE Healthcare

Daiichi Sankyo Company, Limited and GE Healthcare have agreed that, Daiichi Sankyo will return the exclusive development and marketing rights in Japan for four approved diagnostic imaging agents to GE...

Theramex to Acquire Exclusive Rights for BIJUVA

UK-based Theramex has agreed to acquire exclusive licensing and supply rights from TherapeuticsMD to commercialise BIJUVA (estradiol and progesterone capsules) and IMVEXXY (estradiol vaginal inserts) ...

Rafarma Launched Two New Oncology Products

At the beginning of 2019, Rafarma JSC launched the first anticancer drugs Rozustin® (INN Bendamustin) and Pemelan® (INN Pemetrexed) in its own portfolio. Rosustin® for leukemia treatment has become th...

Oasmia Pharmaceutical signs new agreement with Baxter BioPharma Solutions

research tube
Oasmia Pharmaceutical AB (Sweden) announced that the company has signed a new five-year contract with Baxter BioPharma Solutions for global commercial manufacturing of Apealea.

Canon Medical establishes a joint company with ACT Genomics

Canon Medical System Corporation completed the acquisition of the majority shares of ACTmed, a joint venture company established with ACT Genomics, a Taiwanese molecular diagnostic company.

Israeli biotech receives financing to develop precision-medicine technology

stem cells
NewStem, a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness, announced a $4 million financing.

French CDMO will manufacture innovative cancer treatments for Novartis

Novartis signed an agreement with CELLforCURE to produce innovative cancer treatments known as CAR-T therapies (chimeric antigen receptor T-cells) at the bioproduction site based in Les Ulis (Essonne).

French company will set up a production of innovative medicines in Kazakhstan

At the meeting on global investments held in Astana, the companies of Kazakhstan signed 32 commercial documents for the total amount of $4.7 billion.

Peptonic Medical and Orion CMO made a technology transfer agreement

Peptonic Medical AB (Sweden) entered a tech transfer agreement with Orion Contract Manufacturing Organisation (CMO) (Finland) to prepare for the commercial manufacture of VagiVital - a product that Peptonic plans to launch.

Lonza became CAR-Treg cellular product manufacturer for TxCell

lonza building
TxCell and Lonza entered into a Master Service Agreement for the manufacture of TxCell’s HLA-A2 CAR-Treg cellular product (TX200), which is in development for the prevention of chronic rejection after organ transplantation.

3P Biopharmaceuticals signed a contract manufacturing agreement with Intervacc

3P Biopharmaceuticals, a Spanish biotechnology company, and the Swedish company Intervacc completed negotiations and signed the agreement for contract manufacturing of Strangvac®.

SPICs should involve the transfer of unique technologies

fas russia
“Special Investment Contract cannot provide guarantees for the implementation of unfair activities,” said Timofey Nizhegorodtsev, the Head of the Department for Control over Social Sphere and Trade of FAS of Russia.

Takeda Russia continues strategic development of its oncology area

In the near future, the company will localize the manufacturing of several innovative products in Russia. The transfer of manufacturing to Russia will increase the availability of the drug and contribute to reducing its price.

A new training center will be established in NovaMedica Innotech

nova medica
NovaMedica has announced the collaboration in the area of knowledge and technology transfer between NovaMedica Innotech, an R&D center, and Evonik, a German company

Telix Pharmaceuticals will transfer its technology to Japan

Telix Pharmaceuticals, a biopharmaceutical company focused on the development of targeted radiopharmaceuticals or “molecularly-targeted radiation”, announced the establishment Telix Pharmaceuticals Japan

Amgen will transfer technology for manufacturing of blinatumomab to Pharmstandard

Amgen and Pharmstandard announced the signing of an agreement on technology transfer, manufacturing and commercialization of blinatumomab in the Russian market